See More Hear More Watch More Hear More Get on iTunes
Bloomberg First Word BloombergFirst

ACADIA Pharmaceuticals

ACADIA Pharmaceuticals shares are down in trading after it's CEO retired. The company said that the delayed application was due to the need for the company to make sure that it could support the production and distribution of the treatment in case it was approved by regulators. #FinancialNews


More from